|
Rx DTC ADS MAY OFFER MORE THAN THEY DELIVER, FDA SURVEY FINDS
The direct-to-consumer (DTC) advertisements from pharmaceutical firms may increase patient awareness of healthcare conditions, but they also could lead patients to overestimate a drug's benefits, according to a new FDA study. This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives